Wealth Enhancement Advisory Services LLC Raises Position in Transcat, Inc. (NASDAQ:TRNS)

Wealth Enhancement Advisory Services LLC lifted its position in Transcat, Inc. (NASDAQ:TRNS - Free Report) by 28.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 79,303 shares of the scientific and technical instruments company's stock after purchasing an additional 17,743 shares during the period. Wealth Enhancement Advisory Services LLC owned about 0.87% of Transcat worth $9,577,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in TRNS. Conestoga Capital Advisors LLC raised its position in shares of Transcat by 0.3% during the 2nd quarter. Conestoga Capital Advisors LLC now owns 769,361 shares of the scientific and technical instruments company's stock worth $92,077,000 after purchasing an additional 2,155 shares during the last quarter. Hood River Capital Management LLC increased its stake in Transcat by 21.6% during the 2nd quarter. Hood River Capital Management LLC now owns 196,838 shares of the scientific and technical instruments company's stock worth $23,558,000 after buying an additional 34,947 shares in the last quarter. Silvercrest Asset Management Group LLC raised its holdings in shares of Transcat by 4.6% during the first quarter. Silvercrest Asset Management Group LLC now owns 58,381 shares of the scientific and technical instruments company's stock valued at $6,505,000 after acquiring an additional 2,542 shares during the last quarter. Essex Investment Management Co. LLC lifted its position in shares of Transcat by 0.4% in the third quarter. Essex Investment Management Co. LLC now owns 43,444 shares of the scientific and technical instruments company's stock valued at $5,247,000 after acquiring an additional 171 shares in the last quarter. Finally, Bank of New York Mellon Corp boosted its stake in shares of Transcat by 23.5% in the second quarter. Bank of New York Mellon Corp now owns 33,181 shares of the scientific and technical instruments company's stock worth $3,971,000 after acquiring an additional 6,315 shares during the last quarter. 98.34% of the stock is currently owned by institutional investors and hedge funds.

Transcat Stock Down 0.5 %

NASDAQ:TRNS traded down $0.45 on Wednesday, hitting $99.00. The stock had a trading volume of 267,893 shares, compared to its average volume of 52,596. The company has a fifty day moving average price of $122.86 and a two-hundred day moving average price of $122.18. Transcat, Inc. has a 1-year low of $84.45 and a 1-year high of $147.12. The stock has a market cap of $905.85 million, a price-to-earnings ratio of 58.58 and a beta of 0.67.

Transcat (NASDAQ:TRNS - Get Free Report) last announced its quarterly earnings results on Monday, October 28th. The scientific and technical instruments company reported $0.35 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.47 by ($0.12). The firm had revenue of $67.83 million for the quarter, compared to analyst estimates of $70.30 million. Transcat had a return on equity of 8.48% and a net margin of 5.69%. The firm's quarterly revenue was up 8.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.41 EPS. As a group, analysts anticipate that Transcat, Inc. will post 2.06 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research firms recently commented on TRNS. Northland Securities reduced their price objective on Transcat from $130.00 to $110.00 and set a "market perform" rating for the company in a research note on Wednesday. StockNews.com cut shares of Transcat from a "hold" rating to a "sell" rating in a research report on Tuesday. Oppenheimer reissued an "outperform" rating and issued a $130.00 price target (down from $155.00) on shares of Transcat in a research note on Wednesday. HC Wainwright reaffirmed a "buy" rating and set a $156.00 price objective on shares of Transcat in a research note on Tuesday. Finally, Craig Hallum decreased their target price on shares of Transcat from $138.00 to $113.00 and set a "buy" rating on the stock in a research note on Wednesday. One research analyst has rated the stock with a sell rating, two have issued a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, Transcat currently has an average rating of "Hold" and an average price target of $127.25.

Transcat Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.